Abstract

Key words inavolisib - PI3K inhibitor - breast cancer - Ullmann coupling

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract LB449: Strategies to overcome resistance to PI3Kalpha-selective inhibitors mediated by acquired alterations in the PI3K/AKT pathway
Ferran Fece De La Cruz ... Haley Barnes
American Journal of Cancer | VOL. 84
Ferran Fece De La Cruz, et. al.Ferran Fece De La Cruz ... Haley Barnes
05 Apr 2024
Abstract 4501: INK1117: A potent and orally efficacious PI3Kα-selective inhibitor for the treatment of cancer
Katayoun A Jessen ... Yi Liu
American Journal of Cancer | VOL. 71
Katayoun A Jessen, et. al.Katayoun A Jessen ... Yi Liu
15 Apr 2011
Abstract 2830: Discovery of AZD8835, a potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of PIK3CA-dependent cancers
Bernard Barlaam ... Remy Morgentin
American Journal of Cancer | VOL. 75
Bernard Barlaam, et. al.Bernard Barlaam ... Remy Morgentin
01 Aug 2015
Abstract 4482: Discovery of an irreversible PI3Kα-specific Inhibitor
Lixin Qiao ... Mariana Nacht
American Journal of Cancer | VOL. 71
Lixin Qiao, et. al.Lixin Qiao ... Mariana Nacht
15 Apr 2011
View more papers

More From: Synfacts

Paper Title
Journal
Date
Author
All PDFs of this category
-
Synfacts | VOL. -
--
14 Jun 2024
Direct Allylic C–H Amination of Alkenes with Amines to Branched Allylic Amines under Dual Catalysis
-
Synfacts | VOL. -
--
14 Jun 2024
AlCl3- and HFIP-Mediated Selective Deprotection of the N-Cbz Group
-
Synfacts | VOL. -
--
14 Jun 2024
Total Synthesis of Nominal Melognine
-
Synfacts | VOL. -
--
14 Jun 2024
View more papers